NDC 63323-284-41 - VANCOMYCIN HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-284
- Requested NDC
- 63323-284-41
- Package NDCs from labels
- 63323-284-01, 63323-284-20, 63323-284-21, 63323-284-42, 63323-284-26, 63323-284-41, 63323-284-45
- Manufacturer
- Fresenius Kabi USA, LLC | Xellia Pharmaceuticals ApS | GLAND PHARMA LIMITED
- Effective date
- 2025-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE - Fresenius Kabi USA, LLC | Xellia Pharmaceuticals ApS | GLAND PHARMA LIMITED | Fresenius Kabi USA, LLC | Xellia Pharmaceuticals ApS | GLAND PHARMA LIMITED | 2025-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| VANCOMYCIN HYDROCHLORIDE - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
| VANCOMYCIN HYDROCHLORIDE - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-08-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Vancomycin Hydrochloride - Fresenius Kabi, LLC | Xellia Pharmaceuticals ApS | Fresenius Kabi, LLC | Xellia Pharmaceuticals ApS | 2022-12-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-284-01 | VANCOMYCIN HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | 17 | |
| 63323-284-20 | VANCOMYCIN HYDROCHLORIDE | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 17 | |
| 63323-284-26 | VANCOMYCIN HYDROCHLORIDE | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 8 | |
| 63323-284-42 | VANCOMYCIN HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | 8 | |
| 63323-284-41 | Vancomycin Hydrochloride | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | 5 | |
| 63323-284-45 | Vancomycin Hydrochloride | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-284-21 | VANCOMYCIN HYDROCHLORIDE | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 | |
| 63323-284-21 | VANCOMYCIN HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-284 | VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 16 | Current NDC, Legacy NDC, 2 package rows | 20240328_f604d399-fded-4f4f-8efe-af558ed07b9d.zip |
| 63323-284 | VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 8 | Current NDC, Legacy NDC, 2 package rows | 20240404_0576803d-95de-4a48-806a-69ae3fcaf6b0.zip |
| 63323-284 | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20221209_418c3c6a-d08d-448c-89c9-54e558c1ce16.zip |
| 63323-284 | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241019_83ea3faf-fedd-4725-911f-d71a23ec5d5e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-284-01 | EA - Each | 63323-284 | 4f14b5a3-79c4-48b7-bdf2-b9ce378d63df | 1 | 2021-07-15 |
| 63323-284-20 | EA - Each | 63323-284 | d35e820f-cbba-476d-9ea6-28b08a919919 | 1 | 2013-02-13 |
| 63323-284-21 | EA - Each | 63323-284 | 868b29d1-7274-437c-adbf-b05628fe92f8 | 1 | 2016-02-04 |
| 63323-284-26 | EA - Each | 63323-284 | 6688da60-5b9e-42a8-82e1-794deca75a69 | 1 | 2015-09-10 |
| 63323-284-41 | EA - Each | 63323-284 | 9ca01873-7d4f-4799-8623-83f2ae99d4e0 | 1 | 2018-02-20 |
| 63323-284-42 | EA - Each | 63323-284 | dd09a04e-3c86-47d9-905a-8e7268e8f776 | 1 | 2021-11-09 |
| 63323-284-45 | EA - Each | 63323-284 | a59758c0-c0c7-4af4-9b4e-7245d83a2c91 | 1 | 2018-02-20 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE | ACTIVE INGREDIENT | 71WO621TJD | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 3 | |
| VANCOMYCIN | ACTIVE MOIETY | 6Q205EH1VU | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 3 | |
| VANCOMYCIN HYDROCHLORIDE | ACTIVE INGREDIENT | 71WO621TJD | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| VANCOMYCIN | ACTIVE MOIETY | 6Q205EH1VU | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Cameron Pharmaceuticals | bc737938-ae36-460b-a2a8-609f3fe59156 | 2026-08-17 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 127d95d1-8070-41ac-8343-3168b0cf1312 | 2026-08-05 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Avenacy, LLC | c757e65b-ca6f-4c00-afe2-025962b43d31 | 2026-07-31 | Warnings, Adverse reactions | 1807518 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Redpharm Drug | 57d23aed-a3f7-f92e-e063-6394a90add7d | 2026-07-30 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | b01aaa02-8f1d-4b57-96a5-337503428af1 | 2026-07-20 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 033efc76-11d5-4a93-91de-56ed41bab9c3 | 2026-07-08 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 7bbd2c81-33d9-4397-8795-8b9fa28cb5cf | 2026-06-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | d6b8147b-5f93-49ee-8b27-78fe58987c90 | 2026-06-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 28fe3c01-cf87-41c0-87fd-f93a40524335 | 2026-06-16 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Eurofarma, Inc. | 826510bd-b611-42d9-a574-ec7ee4151ef5 | 2026-06-12 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 6c74b360-022a-4c4d-9e4b-0988219a78fb | 2026-06-12 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 8193f588-a032-451e-a0a1-819a5ea834c8 | 2026-06-12 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 99e523d8-9bde-43cb-8434-497015e5dcbd | 2026-06-09 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | a09c589b-e7f4-457c-827f-e1bfa1b26700 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 786bde33-9aec-4b4d-ba46-90bfd61956d0 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 9b6a7a21-4fde-40c6-a420-a8546a4dc701 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Slate Run Pharmaceuticals, LLC | 6ea38b4d-a6d2-4826-8110-ae42c9f7a42a | 2026-05-15 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Slate Run Pharmaceuticals, LLC | 57f58371-3ce6-4983-89df-acba33d1139a | 2026-05-15 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 74056e26-57fd-448e-af76-edbccfc3efb7 | 2026-04-07 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Civica, Inc | 3e041ec6-811b-4f26-9303-959cb09d5f57 | 2026-04-02 | Warnings, Adverse reactions | 1807513 71WO621TJD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.